Cargando…
Early Postoperative Low Expression of RAD50 in Rectal Cancer Patients Associates with Disease-Free Survival
Background: Molecular biomarkers have the potential to predict response to the treatment of rectal cancer. In this study, we aimed to evaluate the prognostic and clinicopathological implication of RAD50 (DNA repair protein RAD50 homolog) expression in rectal cancer. Methods: A total of 266 rectal ca...
Autores principales: | Ho, Vincent, Chung, Liping, Singh, Amandeep, Lea, Vivienne, Revoltar, Maxine, Lim, Stephanie H., Tut, Thein-Ga, Ng, Weng, Lee, Mark, de Souza, Paul, Shin, Joo-Shik, Soon Lee, Cheok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742811/ https://www.ncbi.nlm.nih.gov/pubmed/29189711 http://dx.doi.org/10.3390/cancers9120163 |
Ejemplares similares
-
Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
por: Ho, Vincent, et al.
Publicado: (2018) -
MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response
por: Ho, Vincent, et al.
Publicado: (2016) -
Aberrant Expression of RAD52, Its Prognostic Impact in Rectal Cancer and Association with Poor Survival of Patients
por: Ho, Vincent, et al.
Publicado: (2020) -
Radiotherapy Response in Microsatellite Instability Related Rectal Cancer
por: Shin, Joo-Shik, et al.
Publicado: (2013) -
MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer
por: Situ, Yiling, et al.
Publicado: (2019)